Literature DB >> 15380780

Requirements for Th1-dependent immunity against infection with Leishmania major.

Esther von Stebut1, Mark C Udey.   

Abstract

Protective immunity against cutaneous leishmaniasis is dependent on the induction of Th1/Tc1 immune responses resulting in efficient parasite elimination. In this review, the mechanisms leading to protection are discussed with special focus on the role of Leishmania major-infected dendritic cells (DC) in induction of Th1-dependent immunity. Murine strain-dependent differences between DC derived from Leishmania-susceptible as compared to resistant mice are highlighted.

Entities:  

Mesh：

Year:  2004        PMID： 15380780     DOI： 10.1016/j.micinf.2004.05.024

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  23 in total

Review 1.  Functional diversity and plasticity of human dendritic cell subsets.

Authors:  Tomoki Ito; Yong-Jun Liu; Norimitsu Kadowaki
Journal:  Int J Hematol       Date:  2005-04       Impact factor: 2.490

Review 2.  Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies.

Authors:  Ifeoma Okwor; Jude Uzonna
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis.

Authors:  Marie Breton; Michel J Tremblay; Marc Ouellette; Barbara Papadopoulou
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Miltefosine efficiently eliminates Leishmania major amastigotes from infected murine dendritic cells without altering their immune functions.

Authors:  Klaus Griewank; Caroline Gazeau; Andreas Eichhorn; Esther von Stebut
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

5.  Sepsis induced by cecal ligation and puncture.

Authors:  Haitao Wen
Journal:  Methods Mol Biol       Date:  2013

6.  Construction of a Novel DNA Vaccine Candidate encoding LmSTI1-PpSP42 Fusion Protein from Leishmania major and Phlebotomus papatasi against Cutaneous Leishmaniasis.

Authors:  Touraj Miandoabi; Fariborz Bahrami; Vahideh Moein Vaziri; Soheila Ajdary
Journal:  Rep Biochem Mol Biol       Date:  2018-10

7.  IL-1 signalling is dispensable for protective immunity in Leishmania-resistant mice.

Authors:  Kordula Kautz-Neu; Susanna L Kostka; Stephanie Dinges; Yoichiro Iwakura; Mark C Udey; Esther von Stebut
Journal:  Exp Dermatol       Date:  2010-10-18       Impact factor: 3.960

8.  A role for leukocyte-derived IL-1RA in DC homeostasis revealed by increased susceptibility of IL-1RA-deficient mice to cutaneous leishmaniasis.

Authors:  Kordula Kautz-Neu; Susanna Lopez Kostka; Stephanie Dinges; Yoichiro Iwakura; Mark C Udey; Esther von Stebut
Journal:  J Invest Dermatol       Date:  2011-04-28       Impact factor: 8.551

9.  Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials.

Authors:  Anne Maurer-Cecchini; Saskia Decuypere; François Chappuis; Coralie Alexandrenne; Simonne De Doncker; Marleen Boelaert; Jean-Claude Dujardin; Louis Loutan; Jean-Michel Dayer; Gianfranco Tulliano; Jorge Arevalo; Alexandro Llanos-Cuentas; Carlo Chizzolini
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

10.  IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice.

Authors:  Susanna Lopez Kostka; Stephanie Dinges; Klaus Griewank; Yoichiro Iwakura; Mark C Udey; Esther von Stebut
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.